Polymorphisms risk modeling for vascular toxicity in patients with glioblastoma treated on NRG Oncology/RTOG 0825.

被引：0

作者：

Zhou, Renke

Scheurer, Michael E.

Gilbert, Mark R.

Bondy, Melissa

Sulman, Erik P.

Yuan, Ying

Liu, Yanhong

Vera, Elizabeth

Wendland, Merideth M.

Brachman, David

Bearden, James

McGovern, Susan Lynne

Wilson, Steven S.

Judy, Kevin D.

Robins, H. Ian

Hunter, Grant Kirton

Pugh, Stephanie L.

Armstrong, Terri S.

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[4] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA

[5] Willamette Valley Canc Inst, Eugene, OR USA

[6] Univ Arizona, Canc Ctr, Phoenix Accruals Arizona Oncol Serv Fdn, Phoenix, AZ USA

[7] Southeast Canc Control Consortium Inc, CCOP, Winston Salem, NC USA

[8] UPMC Canc Ctr, New Castle, PA USA

[9] Thomas Jefferson Univ, Philadelphia, PA 19107 USA

[10] Univ Wisconsin, Comprehens Canc Ctr, Madison, WI USA

[11] Intermountain Healthcare, Murray, UT USA

[12] NRG Oncol, Philadelphia, PA USA

[13] Univ Texas Hlth Sci Ctr Houston, Sch Nursing, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.2049

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2049

引用

页数：2

共 42 条

[21] NRG Oncology RTOG 0415: A randomized phase III non-inferiority study comparing two fractionation schedules in patients with low-risk prostate cancer
Lee, W. Robert
Dignam, James J.
Amin, Mahul
Bruner, Deborah
Low, Daniel
Swanson, Gregory P.
Shah, Amit
D'Souza, David
Michalski, Jeff M.
Dayes, Ian
Seaward, Samantha A.
Hall, William Adrian
Nguyen, Paul L.
Pisansky, Thomas Michael
Faria, Sergio
Chen, Yuhchyau
Koontz, Bridget F.
Paulus, Rebecca
Sandler, Howard M.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[22] Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer The NRG Oncology RTOG 0126 Randomized Clinical Trial
Michalski, Jeff M.
Moughan, Jennifer
Purdy, James
Bosch, Walter
Bruner, Deborah W.
Bahary, Jean-Paul
Lau, Harold
Duclos, Marie
Parliament, Matthew
Morton, Gerard
Hamstra, Daniel
Seider, Michael
Lock, Michael I.
Patel, Malti
Gay, Hiram
Vigneault, Eric
Winter, Kathryn
Sandler, Howard
JAMA ONCOLOGY, 2018, 4 (06)
[23] Risk factors for grade 2+ late bladder toxicity among patients treated on protocol RTOG 94-06
Tucker, S. L.
Dong, L.
Michalski, J. M.
Bosch, W.
Winter, K.
Mohan, R.
Kuban, D.
Cheung, M. R.
Lee, A. K.
Cox, J. D.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S65 - S66
[24] Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811
Doll, Corinne M.
Moughan, Jennifer
Klimowicz, Alexander
Ho, Clement K.
Kornaga, Elizabeth N.
Lees-Miller, Susan P.
Ajani, Jaffer A.
Crane, Christopher H.
Kachnic, Lisa A.
Okawara, Gordon S.
Berk, Lawrence B.
Roof, Kevin S.
Becker, Mark J.
Grisell, David L.
Ellis, Robert J.
Sperduto, Paul W.
Marsa, Gerald W.
Guha, Chandan
Magliocco, Anthony M.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (03): : 554 - 562
[25] Pathologic complete response and survival outcomes in patients with localized soft tissue sarcoma treated with neoadjuvant chemoradiotherapy or radiotherapy: Long-term update of NRG Oncology RTOG 9514 and 0630.
Wang, Dian
Harris, Jonathan
Kraybill, William G.
Eisenberg, Burton Larry
Kirsch, David G.
Kane, John Michael
Ettinger, David S.
Spiro, Ira J.
Trotti, Andy
Freeman, Carolyn R.
Chen, Yen -Lin
Hitchcock, Ying J.
Bedi, Manpreet
Salerno, Kilian Elizabeth
Dundas, George
Godette, Karen D.
Larrier, Nicole
Curran, Walter John
Lucas, David Robert
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[26] Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer
Lee, W. Robert
Dignam, James J.
Amin, Mahul B.
Bruner, Deborah W.
Low, Daniel
Swanson, Gregory P.
Shah, Amit B.
D'Souza, David
Michalski, Jeff M.
Dayes, Ian S.
Seaward, Samantha A.
Hall, William A.
Nguyen, Paul L.
Pisansky, Thomas M.
Faria, Sergio L.
Chen, Yuhchyau
Rodgers, Joseph P.
Sandler, Howard M.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (20) : 2377 - 2381
[27] Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06
Tucker, Susan L.
Michalski, Jeff M.
Bosch, Walter R.
Mohan, Radhe
Dong, Lei
Winter, Kathryn
Purdy, James A.
Cox, James D.
RADIOTHERAPY AND ONCOLOGY, 2012, 104 (01) : 109 - 113
[28] Re: Long-term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients with Low-Risk Prostate Cancer
Gandaglia, Giorgio
Barletta, Francesco
Briganti, Alberto
Montorsi, Francesco
EUROPEAN UROLOGY, 2025, 87 (03) : 372 - 373
[29] NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results
Bruner, D. Watkins
Pugh, S. L.
Lee, W. R.
Dignam, J. J.
Low, D.
Swanson, G. P.
Shah, A. B.
D'Souza, D. P.
Michalski, J. M.
Dayes, I. S.
Seaward, S. A.
Nguyen, P. L.
Hall, W. A.
Pisansky, T. M.
Chen, Y.
Sandler, H. M.
Movsas, B.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S2 - S3
[30] Conditional Risk and Predictive Factors Associated with Late Toxicity for Prostate Cancer Patients Treated with External Beam Radiotherapy Alone on Randomized Trial RTOG 0126
Alexander, G. S.
Krc, R. F.
Assif, J. W.
Sun, K.
Molitoris, J. K.
Tran, P. T.
Bentzen, S. M.
Rana, Z. H.
Mishra, M. V.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S94 - S94

← 1 2 3 4 5 →